We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Journal of Comparative Effectiveness Research
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Microdissected tissue: an underestimated source for biomarker discovery?

    Ferdinand von Eggeling

    † Author for correspondence

    Institute of Human Genetics and Anthropology, Core Unit Chip Application, Medical Faculty at the Friedrich Schiller University Jena, Jena, Germany.

    &
    Günther Ernst

    Institute of Human Genetics and Anthropology, Core Unit Chip Application, Medical Faculty at the Friedrich Schiller University Jena, Jena, Germany.

    Published Online:https://doi.org/10.2217/17520363.1.2.217
    Free first page

    Bibliography

    • Wulfkuhle JD, Liotta LA, Petricoin EF: Proteomic applications for the early detection of cancer. Nat. Rev. Cancer3,267–275 (2003).Crossref, Medline, CASGoogle Scholar
    • van de Vijver MJ, He YD, van’t Veer LJ et al.: A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med.347,1999–2009 (2002).Crossref, Medline, CASGoogle Scholar
    • Semmes OJ, Feng Z, Adam BL et al.: Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.Clin. Chem.51,102–112 (2005).Crossref, Medline, CASGoogle Scholar
    • Kozak KR, Amneus MW, Pusey SM et al.: Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis. Proc. Natl Acad. Sci. USA100,12343–12348 (2003).Crossref, Medline, CASGoogle Scholar
    • Melle C, Ernst G, Schimmel B et al.: Discovery and identification of α-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology129,66–73 (2005).Crossref, Medline, CASGoogle Scholar
    • Brazma A, Hingamp P, Quackenbush J et al.: Minimum information about a microarray experiment (MIAME) – toward standards for microarray data. Nat. Genet.29,365–371 (2001).Crossref, Medline, CASGoogle Scholar
    • Taylor CE: Minimum reporting requirements for proteomics: a MIAPE primer. Proteomics (6 Suppl. 2),39–44 (2006).Crossref, MedlineGoogle Scholar
    • 101  Minimum Information About a Microarray Experiment www.mged.org/workgroups/miame/miame.htmlGoogle Scholar
    • 102  Minimum Information About a Proteomics Experiment http://psidev.sourceforge.net/Google Scholar